Page last updated: 2024-10-26

diphenyleneiodonium and Encapsulating Peritoneal Sclerosis

diphenyleneiodonium has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, J1
Jiang, Z1
Zhang, H1
Zhu, H1
Zhou, SF1
Yu, X1

Other Studies

1 other study available for diphenyleneiodonium and Encapsulating Peritoneal Sclerosis

ArticleYear
NADPH oxidase-dependent formation of reactive oxygen species contributes to angiotensin II-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells.
    International journal of molecular medicine, 2011, Volume: 28, Issue:3

    Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cadheri

2011